Atlas Trials

Revimmune

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Revimmune

RecordFirmDate
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort) (NCT04927169)Revimmune2021-03-01
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ) (NCT04426201)Revimmune2020-12-20
Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lung Disease (NCT04154826)Revimmune2020-11-30
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ) (NCT04442178)Revimmune2020-09-15
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort (NCT04407689)Revimmune2020-06-08
InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort (NCT04379076)Revimmune2020-05-14
Recombinant Interleukin-7 (CYT107) to Restore Absolute Lymphocyte Counts in Sepsis Patients (NCT03821038)Revimmune2019-06-01

Track Revimmune automatically

Every clearance here is in the API, with alerts when new ones post.